CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+6.25%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$17.4B
AUM Growth
+$904M
(+5.5%)
Cap. Flow
+$91.5M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
29.78%
Holding
731
New
36
Increased
329
Reduced
218
Closed
40
Top Buys
| 1 |
Amgen
AMGN
|
$65.4M |
| 2 |
Amazon
AMZN
|
$57.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$54.5M |
| 4 |
BioNTech
BNTX
|
$41.3M |
| 5 |
Advanced Micro Devices
AMD
|
$40.5M |
Top Sells
| 1 |
Lam Research
LRCX
|
$122M |
| 2 |
Thermo Fisher Scientific
TMO
|
$63.5M |
| 3 |
Applied Materials
AMAT
|
$43.1M |
| 4 |
Nu Holdings
NU
|
$36.4M |
| 5 |
Incyte
INCY
|
$33.7M |
Sector Composition
| 1 | Technology | 31.8% |
| 2 | Healthcare | 28.54% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 7.84% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Zai Lab
ZLAB
$3.42B
| $9.41M | 0.05% |
390,023
+25,010
| +7% | +$604K |
|
277
Pliant Therapeutics
PLRX
$114M
| $9.34M | 0.05% |
833,216
| – | – |
|
278
Praxis Precision Medicines
PRAX
$986M
| $9.32M | 0.05% |
+162,031
| New | +$9.32M |
|
279
Scholar Rock
SRRK
$3.02B
| $9.26M | 0.05% |
1,155,536
+411,093
| +55% | +$3.29M |
|
280
Neumora Therapeutics
NMRA
$272M
| $8.93M | 0.05% |
+676,244
| New | +$8.93M |
|
281
Option Care Health
OPCH
$4.72B
| $8.81M | 0.05% |
281,512
+43,957
| +19% | +$1.38M |
|
282
Cigna
CI
$81.5B
| $8.58M | 0.05% |
24,762
-45,949
| -65% | -$15.9M |
|
283
Graphic Packaging
GPK
$6.38B
| $8.52M | 0.05% |
287,909
-276,055
| -49% | -$8.17M |
|
284
ConocoPhillips
COP
$116B
| $8.5M | 0.05% |
80,718
+875
| +1% | +$92.1K |
|
285
Synchrony
SYF
$28.1B
| $8.42M | 0.05% |
168,908
-486,265
| -74% | -$24.3M |
|
286
Globus Medical
GMED
$8.18B
| $8.42M | 0.05% |
117,689
+40,023
| +52% | +$2.86M |
|
287
Guardant Health
GH
$7.5B
| $8.4M | 0.05% |
366,145
| – | – |
|
288
Edwards Lifesciences
EW
$47.5B
| $8.4M | 0.05% |
127,235
-73,090
| -36% | -$4.82M |
|
289
Twilio
TWLO
$16.7B
| $8.28M | 0.05% |
127,027
-35,171
| -22% | -$2.29M |
|
290
Electronic Arts
EA
$42.2B
| $8.25M | 0.05% |
57,501
-50,044
| -47% | -$7.18M |
|
291
LKQ Corp
LKQ
$8.33B
| $8.11M | 0.05% |
203,072
+48,412
| +31% | +$1.93M |
|
292
Encompass Health
EHC
$12.6B
| $8.02M | 0.05% |
82,974
+20,948
| +34% | +$2.02M |
|
293
Equity Residential
EQR
$25.5B
| $8.02M | 0.05% |
107,674
+74,516
| +225% | +$5.55M |
|
294
Veracyte
VCYT
$2.55B
| $7.89M | 0.05% |
231,676
-439,261
| -65% | -$15M |
|
295
Edgewise Therapeutics
EWTX
$1.64B
| $7.86M | 0.05% |
294,624
-34,376
| -10% | -$917K |
|
|
ITOS
296
DELISTED
iTeos Therapeutics
ITOS
| $7.85M | 0.05% |
769,213
+259,910
| +51% | +$2.65M |
|
297
Relay Therapeutics
RLAY
$710M
| $7.74M | 0.04% |
1,092,705
+389,276
| +55% | +$2.76M |
|
298
Sempra
SRE
$52.9B
| $7.63M | 0.04% |
91,223
+3,073
| +3% | +$257K |
|
299
Sarepta Therapeutics
SRPT
$1.96B
| $7.43M | 0.04% |
59,508
-69,492
| -54% | -$8.68M |
|
300
KB Financial Group
KB
$28.5B
| $7.36M | 0.04% |
4,279
| – | – |
|